Merkc

FDA grants priority review for Daiichi Sankyo-Merck’s lung cancer therapy
Pharmaceutical Business Review
Wed, 12/27/23 - 11:00 pm
Daiichi Sankyo
Merkc
patritumab deruxtecan
FDA
non-small cell lung cancer
Merck ends trial of Intercell's MRSA vaccine
Yahoo/AP
Wed, 06/8/11 - 08:29 am
Intercell
vaccines
Merkc
MRSA
V710